Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05692882
NA

A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China

Sponsor: Sino Medical Sciences Technology Inc.

View on ClinicalTrials.gov

Summary

The primary objective of this trial is to evaluate the long-term safety and efficacy of the NOVA intracranial drug-eluting stent system in "real world" patients with intracranial atherosclerotic stenosis.

Official title: To Evaluate the Safety and Efficacy of the NOVA Intracranial Drug-eluting Stent System in "real World" Patients with Intracranial Atherosclerotic Stenosis: a Prospective, Multicenter, Post-marketing Registry Clinical Study (NOVA II)

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

1000

Start Date

2023-11-16

Completion Date

2029-12-30

Last Updated

2025-04-01

Healthy Volunteers

No

Interventions

DEVICE

Drug-Eluting Stents

The NOVA stent is a sirolimus-eluting stent system designed for intracranial artery stenosis with a rapid exchangeable balloon

Locations (5)

First People's Hospital of Chenzhou

Chenzhou, China

Ganzhou People's Hospital

Ganzhou, China

Jinhua Municipal Central Hospital

Jinhua, China

The First Affiliated Hospital of Ningbo University

Ningbo, China

Shanxi Cardiovascular Hospital

Shanxi, China